PREDICT: Prospective Regional Epilepsy Database

Sponsor
Sahlgrenska University Hospital, Sweden (Other)
Overall Status
Recruiting
CT.gov ID
NCT04559919
Collaborator
(none)
1,000
2
132.5
500
3.8

Study Details

Study Description

Brief Summary

PREDICT is an observational study following adults with an unprovoked seizure or epilepsy in the health care region of western Sweden. The objective is to identify biomarkers and/or genetic predisposition of relevance for diagnosis and/or treatment of epilepsy and study the long-term prognosis and consequences of epilepsy.

Condition or Disease Intervention/Treatment Phase
  • Other: Seizure status
  • Diagnostic Test: Tests
  • Other: Epilepsy
  • Other: Demographics and psychosocial
  • Other: Health care

Detailed Description

Adults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in the health care region of western Sweden (VGR) at the time of inclusion.

Baseline data and outcome variables are collected from several patient registries: the electronic medical records system in the health care region VGR and Swedish National Registers of healthcare, income, and employment managed by The National Board of Health and Welfare or Statistics Sweden, both of which are government agencies.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment
Actual Study Start Date :
Dec 15, 2020
Anticipated Primary Completion Date :
Dec 31, 2031
Anticipated Study Completion Date :
Dec 31, 2031

Arms and Interventions

Arm Intervention/Treatment
Adults with epilepsy

Adults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in VGR at the time of inclusion. Based on the clinical information, patients can be categorized into relevant groups; single seizure, seizure-free with epilepsy, and drug-resistant epilepsy. Subgroups may also be selected based on age, sex, epilepsy sub-diagnosis, cause of epilepsy, use of a particular antiepileptic drug, or experience of a particular side effect.

Other: Seizure status
We will collect information on first seizure ever, last seizure ever, number of seizure in last two months.

Diagnostic Test: Tests
We will collect results from imaging, electroencephalogram, and laboratory tests.

Other: Epilepsy
We will collect information on risk factors of epilepsy, cause of epilepsy, epilepsy type/syndrome, medications tried, if the epilepsy is drug resistent, side effects of antiepileptic drugs.

Other: Demographics and psychosocial
We will collect information on age, sex, date of death if applicable, marital status, education level, income type, driving status, employment, benefits, sick leave, number of household members.

Other: Health care
We will collect information on received health care; visit dates, caregiver, dispensation dates of antiepileptic drugs

Outcome Measures

Primary Outcome Measures

  1. epilepsy [baseline and years 1,2,3,4,5,6,7,8,9,10]

    more than one seizure after first seizure

  2. seizure status [baseline and years 1,2,3,4,5,6,7,8,9,10]

    the number of seizures in last two months and overall

  3. drug resistant epilepsy [baseline and years 1,2,3,4,5,6,7,8,9,10]

    epilepsy that has not responded to two antiepileptic drugs

  4. severe side effects of antiepileptic drug [baseline and years 1,2,3,4,5,6,7,8,9,10]

  5. psychosocial outcomes [baseline and years 1,2,3,4,5,6,7,8,9,10]

    employment, marital status, income, sick leave

Secondary Outcome Measures

  1. received health care [baseline and years 1,2,3,4,5,6,7,8,9,10]

    the number of visits for epilepsy, missed appointments, time intervals between visits

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Over 18 years of age

  • An unprovoked seizure within the last year or a diagnosis of epilepsy according to the current International League Against Epilepsy definition (epilepsy with seizure in the last ten or antiepileptic drug treatment in the last five years)

Exclusion Criteria:
  • Expected survival less than two years

  • Inability to give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Södra Älvsborgs Sjukhus Borås Sweden
2 Sahlgrenska University Hospital Gothenburg Sweden 41345

Sponsors and Collaborators

  • Sahlgrenska University Hospital, Sweden

Investigators

  • Principal Investigator: Johan Zelano, MD PhD, Sahlgrenska University Hospital, Sweden

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johan Zelano, Consultant Neurologist, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT04559919
Other Study ID Numbers:
  • 2020-00853
First Posted:
Sep 23, 2020
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Johan Zelano, Consultant Neurologist, Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2021